Skip to main content
Premium Trial:

Request an Annual Quote

Supelco, Allele Biotechnology & Pharmaceuticals

Premium
Supelco this week introduced the Ascentis Express HILIC HPLC columns. The columns provide the analysis speed and resolving power of sub-2 micron columns with a 50 percent reduction in backpressure, the company said in a statement. Supelco is a division of Sigma-Aldrich.
 

 
Allele Biotechnology & Pharmaceuticals recently launched its mWasabi monomeric green fluorescent protein. Derived from the company’s mTFP1 fluorescent protein, the mWasabi is almost twice as bright as enhanced green fluorescence protein and has a better excitation spectrum, Jiwu Wang, president of Allele, told ProteoMonitor.

The Scan

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.

Machine Learning Improves Diagnostic Accuracy of Breast Cancer MRI, Study Shows

Combining machine learning with radiologists' interpretations further increased the diagnostic accuracy of MRIs for breast cancer, a Science Translational Medicine paper finds.

Genome Damage in Neurons Triggers Alzheimer's-Linked Inflammation

Neurons harboring increased DNA double-strand breaks activate microglia to lead to neuroinflammation like that seen in Alzheimer's disease, a new Science Advances study finds.

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.